Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_assertion type Assertion NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_head.
- NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_assertion wasGeneratedBy ECO_0000203 NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_provenance.
- NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_assertion wasDerivedFrom befree-20140225 NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_provenance.
- NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_assertion SIO_000772 22358390 NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_provenance.
- NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_assertion evidence source_evidence_literature NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_provenance.
- NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_assertion description "[The aim of this study is to evaluate whether class III β-tubulin (TUBB3) expression could predict progression-free survival or overall survival in relapsed non-small cell lung cancer (NSCLC) patients treated with taxene-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382666.RACi-v65Aut2qFyWSPQ3lCExNiBYe4OTuFpx5zA-A6uOM130_provenance.